Thu, Apr 24, 2014, 5:34 AM EDT - U.S. Markets open in 3 hrs 56 mins


% | $
Quotes you view appear here for quick access.

Arena Pharmaceuticals, Inc. Message Board

  • guido_arnone guido_arnone Jun 20, 2013 1:06 PM Flag

    50 000 highly likely Belviq users just reached

    The Venezuelan community in Florida has 20 000 people registered to vote in their consulate.

    I just sent an e-mail to the newspaper El Venezolano suggesting Belviq as a topic for an article on obesity.

    This newspaper circulates in Houston, Orlando, Broward, and Miami. Total number of Venezuelans in the USA is about 50 000 - 100 000, perhaps more.

    Most of them are affluent, and you can bet those overweight and obese will say "I want that medicine".

    Venezuelan women have the propensity to spend significant amounts of money in their look and appearance (cosmetic surgery, breast implants, etc.), and they can afford it.

    TODZUN: Thank you, this idea arose from one of your mediocre replies.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Last week Arena GmbH submitted a new federal trademark application for "Venespri" for the use in weight management. I read that Venezuela is the largest South American pharmaceutical market behind Brazil. Venespri sounds like a good product name for that market. Just sayin'.

    • I just sent info on Belviq to the New Herald, a Miami newspaper. Also posted the same note as comments to news on obesity, diet, diabetes on a Colombian newspaper (El Colombiano) and a Mexican one (Diario Las Americas). The note in Spanish follows (keywords are almost the same in English):

      Desde hace casi dos semanas se esta vendiendo en Estados Unidos la medicina Belviq (farmaco = Lorcaserin), la cual suprime el apetito sin causar efectos secundarios. Esta medicina fue estudiada en alrededor de 6000 personas durantes 24 meses. Aproximadamente la mitad de estas personas respondio al tratamiento, obteniendose un promedio de 12% de perdida de peso en 12 meses. Un 50% de esta mitad (25% del total) obtuvo una perdida de peso muy superior al promedio de 12% (en este momento no tenga la cifra a la mano). Esta medicina esta indicada para personas obesas (indice de masa corporal mayor que 30) o para personas con sobrepeso (IMC mayor que 27 pero menor que 30) que tengan alguna comorbicidad (presion alta, colesterol alto, etc.). Al cabo de dos o tres meses de tratamiento, el doctor determina si el medicamento es efectivo en el paciente. En caso que no, el tratamiento se discontinua. Se hizo ademas un sub-estudio en personas diabeticas, encontrandose una respuesta muy favorable (particularmente porque es dificil que un paciente diabetico pierda peso) y ademas una inesperada respuesta en los niveles de azucar en la sangre y de una proteina indicadora en la diabetes comparable a los resultados que se obtienen con los medicamentos convencionales para la diabetes. Otro estudio determino que independientemente de si un paciente responde o no al medicamente (en cuanto a adelgazar respecta), todos exhibieron una mejora considerable en los niveles de glucosa, colesterol, etc. Si el paciente esta en regimen de SSRI (Inhibidores de la reabsorcion selectiva de la serotonina), el doctor debe graduar la dosis y controlar al paciente detalladamente para prevenir el sindrome de la seroto

    • You bet! I work with a Venezuelan. Nice guy. Gave up on the country after he was briefly kidnapped and robbed by gun point on another occasion. Shame, country could have taken the Lula/Brazilian route to prosperity but they ended up with Hugo.

    • Nicolas Maduro could use some.

    • How'd they get so d*mn rich??!! This country does not belong to Americans any more sadly...I'm struggling and very educated and experienced.

    • I just got confirmation from the editor of the El Venezolano newspaper that they will publish a note on Belviq in the Health Section, note based on a summary description I gave him by e-mail.

      Target audience: About 200 000 Venezuelans abroad, directly by reading the newspaper, and indirectly by word of mouth (Venezuelans in the States primarily spent time with other Venezuelans, very rich and dense social - networking).

      Sentiment: Strong Buy

6.16-0.18(-2.84%)Apr 23 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.